This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Aug 16;155(4):JC2-4.

doi: 10.7326/0003-4819-155-4-201108160-02004.

ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

Juan Pablo Domecq¹, Gabriela Prutsky, Victor M Montori

Affiliations

PMID: 21844537
DOI: 10.7326/0003-4819-155-4-201108160-02004

Comment

ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

Juan Pablo Domecq et al. Ann Intern Med. 2011.

. 2011 Aug 16;155(4):JC2-4.

doi: 10.7326/0003-4819-155-4-201108160-02004.

Authors

Juan Pablo Domecq¹, Gabriela Prutsky, Victor M Montori

Affiliation

¹ Universidad Peruana Cayetano Heredia, Lima, Peru.

PMID: 21844537
DOI: 10.7326/0003-4819-155-4-201108160-02004

No abstract available

PubMed Disclaimer

Comment on

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.
Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, Marinopoulos SS, Puhan MA, Ranasinghe P, Block L, Nicholson WK, Hutfless S, Bass EB, Bolen S. Bennett WL, et al. Ann Intern Med. 2011 May 3;154(9):602-13. doi: 10.7326/0003-4819-154-9-201105030-00336. Epub 2011 Mar 14. Ann Intern Med. 2011. PMID: 21403054 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon